Drug rediscovery in gastroenterology: from off-label to on-label use of thioguanine in inflammatory bowel disease

被引：2
|
作者：
de Boer, Nanne K. H. [1 ,2 ,6 ]
Simsek, Melek [1 ,3 ]
Meijer, Berrie [1 ,3 ]
Neurath, Markus F. [4 ]
van Bodegraven, Ad [5 ]
Mulder, Chris J. J. [1 ]
机构：
[1] Univ Amsterdam, Gastroenterol & Hepatol, Med Ctr, Amsterdam, Netherlands
[2] Res Inst Amsterdam Gastroenterol Endocrinol Metab, Amsterdam, Noord Holland, Netherlands
[3] Vrije Univ Amsterdam, Sch Med, Amsterdam, Netherlands
[4] Friedrich Alexander Univ Erlangen Nurnberg, Dept Med 1, Erlangen, Germany
[5] Zuyderland Med Ctr, Dept Gastroenterol Geriatr & Intens Care Med Co M, Geleen, Netherlands
[6] Univ Amsterdam, Gastroenterol & Hepatol, Med Ctr, NL-1081 HZ Amsterdam, Netherlands
来源：
GUT | 2023年 / 72卷 / 10期
关键词：
drug development; drug metabolism; inflammatory bowel disease; crohn's disease; azathioprine; ULCERATIVE-COLITIS; THIOPURINE THERAPY; AZATHIOPRINE; PHARMACOGENETICS; INHIBITION; 6-THIOGUANINE; PROLIFERATION; ASSOCIATION; COMBINATION; ACTIVATION;
D O I：
10.1136/gutjnl-2023-329679
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Drug rediscovery refers to the principle of using 'old' drugs outside the indications mentioned in the summary of product characteristics. In the past decades, several drugs were rediscovered in a wide variety of medical fields. One of the most recent examples is the unconditional registration of thioguanine (TG), a thiopurine derivative, in patients with inflammatory bowel disease in the Netherlands. In this paper, we aim to visualise potential hurdles that hamper drug rediscovery in general, emphasise the global need for optimal use and development of potentially useful drugs, and provide an overview of the registration process for TG in the Netherlands. With this summary, we aim to guide drug rediscovery trajectories in the near future.
引用
收藏
页码：1985 / 1991
页数：7
相关论文
共 50 条
  • [11] Safety and efficacy of drug-eluting stents: On-label and off-label perspectives
    Weisz, Giora
    Stone, Gregg W.
    [J]. REVIEWS IN CARDIOVASCULAR MEDICINE, 2008, 9 (01) : 46 - 61
  • [12] Letter: off-label use of hyperbaric oxygen therapy in inflammatory bowel disease
    Lansdorp, Corine A.
    Buskens, Christianne J.
    Gecse, Krisztina B.
    D'Haens, Geert R. A. M.
    van Hulst, Rob A.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (01) : 215 - 216
  • [13] Drug Utilization and Off-label Drug Use in Spanish Pediatric Gastroenterology Outpatients
    Ruiz-Antoran, Belen
    Pineiro, Roi
    Avendano, Cristina
    Roman, Enriqueta
    Luz Cilleruelo, Maria
    Gutierrez-Junquera, Carolina
    Centeno, Gustavo
    Jose Cilleruelo, Maria
    [J]. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2013, 56 (02): : 173 - 177
  • [14] Comparison of Frequency of Complications With On-Label Versus Off-Label Use of Rotational Atherectomy
    Sakakura, Kenichi
    Ako, Junya
    Wada, Hiroshi
    Naito, Ryo
    Funayama, Hiroshi
    Arao, Kenshiro
    Kubo, Norifumi
    Momomura, Shin-ichi
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2012, 110 (04): : 498 - 501
  • [15] Outcomes and complications with off-label versus on-label use of drug-eluting stents: Results from the STENT registry
    Brodie, Bruce R.
    Stuckey, Thomas
    Downey, William
    Humphrey, Angela
    Bradshaw, Barbara
    Metzger, Christopher
    Hermiller, James
    Krainin, Fred
    Juk, Stanley
    Cheek, H. Barrett
    Smith, Henry
    Edmunds, John
    Varanasi, Jayadeep
    Duffy, Peter
    Simonton, Charles A.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2007, 100 (8A): : 42L - 42L
  • [16] The Clinical Trials Portfolio for On-label and Off-label Studies of Eculizumab
    Kim, Myung S.
    Prasad, Vinay
    [J]. JAMA INTERNAL MEDICINE, 2020, 180 (02) : 315 - 317
  • [17] On-label and off-label drugs used in the treatment of male infertility
    Chehab, Mahmoud
    Madala, Alosh
    Trussell, J. C.
    [J]. FERTILITY AND STERILITY, 2015, 103 (03) : 595 - 604
  • [18] Five-year clinical outcomes of drug-eluting stents according to on-label and off-label use
    Park, Kyu-Hwan
    Kim, Ung
    Lee, Chan-Hee
    Son, Jang-Won
    Park, Jong-Seon
    Shin, Dong-Gu
    Kim, Young-Jo
    Cho, Jeong-Hwan
    [J]. KOREAN JOURNAL OF INTERNAL MEDICINE, 2016, 31 (04): : 678 - 684
  • [19] Clinical Outcomes With On-Label and Off-Label Use of the Transcatheter Heart Valve in the United States
    Lardizabal, Joel A.
    Macon, Conrad J.
    O'Neill, Brian P.
    Singh, Vikas
    Martinez, Claudia A.
    Alfonso, Carlos
    Cohen, Mauricio G.
    Williams, Donald B.
    O'Neill, William W.
    Heldman, Alan W.
    [J]. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2014, 84 (01) : 124 - 128
  • [20] Off-label drug use in patients with inflammatory bowel disease: a national survey among tertiary care centres
    Simsek, M.
    Hoentjen, F.
    Oldenburg, B.
    Ponsioen, C. Y.
    van der Woude, J.
    van der Meulen, A. E.
    Pierik, M.
    Dijkstra, G.
    de Boer, N. K.
    [J]. JOURNAL OF CROHNS & COLITIS, 2019, 13 : S472 - S472
12345